Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma

por Baldi, Salem, Khamgan, Hassan, Qian, Yuanyuan, Wu, Han, Zhang, Zhenyu, Zhang, Mengyan, Gao, Yina, Safi, Mohammed, Al-Radhi, Mohammed, Zuo, Yun-Fei
Publicado 2021

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma

por Baldi, Salem, He, Yun, Ivanov, Igor, Khamgan, Hassan, Safi, Mohammed, Alradhi, Mohammed, Shopit, Abdullah, Al-Danakh, Abdullah, Al-Nusaif, Murad, Gao, Yaping, Tian, Hui
Publicado 2022

ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression

por Baldi, Salem, Zhang, Qianshi, Zhang, Zhenyu, Safi, Mohammed, Khamgan, Hassan, Wu, Han, Zhang, Mengyan, Qian, Yuanyuan, Gao, Yina, Shopit, Abdullah, Al‐Danakh, Abdullah, Alradhi, Mohammed, Al‐Nusaif, Murad, Zuo, Yunfei
Publicado 2022